Comment on: TODAY Study Group. Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY. Diabetes Care 2013;36:1749–1757

Benzer Materyaller

• Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY
  Baskı/Yayın Bilgisi: (2013)
• Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes. Diabetes Care 2013;36:124–129
  Yazar:: Lai, Shih-Wei, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Response to Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes. Diabetes Care 2013;36:124–129
  Yazar:: Suissa, Samy, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Comment on: Bernstein. Reducing Foot Wounds in Diabetes. Diabetes Care 2013;36:e48
  Yazar:: Morbach, Stephan, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987
  Yazar:: Goodarzi, Mark O.
  Baskı/Yayın Bilgisi: (2014)